GW406381
CXA30007
Phase 3 small_molecule completed
Quick answer
GW406381 for Osteoarthritis, Knee is a Phase 3 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Osteoarthritis, Knee
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed